GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannonau Corp (OTCPK:CNNC) » Definitions » Growth Rank

CNNC (Cannonau) Growth Rank : 0 (As of Mar. 31, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Cannonau Growth Rank?

Cannonau has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Cannonau Growth Rank Related Terms

Thank you for viewing the detailed overview of Cannonau's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannonau Business Description

Traded in Other Exchanges
N/A
Address
937 Old Seneca Turnpike Road, Skaneateles, NY, USA, 13252-9318
Cannonau Corp is using cutting-edge nanotechnology plans to offer Cannabidiol (CBD) for improved bioavailability and maximum benefit. It believes that its formulas can be easily incorporated into a wide, offering customers an advantage when it counts.

Cannonau Headlines

From GuruFocus

Cannonau Corporation Announces New Medical Advisor

By ACCESSWIRE ACCESSWIRE 05-18-2021

Cannonau Corporation Launches New CBD Website

By ACCESSWIRE ACCESSWIRE 02-16-2021

Cannonau Corporation Announces New Cannabis Legal Advisor

By ACCESSWIRE ACCESSWIRE 05-11-2021

CANNONAU CORP. Submits Application For Uplisting To OTCQB

By ACCESSWIRE ACCESSWIRE 03-08-2021